External Control Arms in Idiopathic Pulmonary Fibrosis Using Clinical Trial and Real World Data Sources.
American journal of respiratory and critical care medicine(2023)
摘要
IPF ECs generated from historical RCT placebo arms result in comparable primary treatment effects to that of the original clinical trial, while ECs from real-world data sources, including registry or EHR data, do not. RCT-ECs may serve as a potentially useful supplement to future IPF RCTs.
更多查看译文
关键词
idiopathic pulmonary fibrosis,pulmonary fibrosis,real-world
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要